161 related articles for article (PubMed ID: 29321236)
21. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia.
Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ
Intensive Care Med; 2008 Nov; 34(11):2084-91. PubMed ID: 18523752
[TBL] [Abstract][Full Text] [Related]
22. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation.
Naya T; Yukiiri K; Hosomi N; Takahashi T; Ohkita H; Mukai M; Koziol JA; Kohno M
Cerebrovasc Dis; 2008; 26(4):434-40. PubMed ID: 18799875
[TBL] [Abstract][Full Text] [Related]
23. Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.
Khaleghi M; Al-Omari MA; Kondragunta V; Morgenthaler NG; Struck J; Bergmann A; Mosley TH; Kullo IJ
Am J Cardiol; 2009 May; 103(9):1255-60. PubMed ID: 19406268
[TBL] [Abstract][Full Text] [Related]
24. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.
Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W
PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
26. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage.
Luani B; Rauwolf T; Groscheck T; Tanev I; Herold J; Isermann B; Schmeisser A; Braun-Dullaeus RC
Heart Lung Circ; 2018 Jul; 27(7):828-834. PubMed ID: 28818408
[TBL] [Abstract][Full Text] [Related]
27. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
28. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
29. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP.
Boeck L; Eggimann P; Smyrnios N; Pargger H; Thakkar N; Siegemund M; Marsch S; Rakic J; Tamm M; Stolz D
Eur Respir J; 2011 Mar; 37(3):595-603. PubMed ID: 20530040
[TBL] [Abstract][Full Text] [Related]
30. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
31. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
[TBL] [Abstract][Full Text] [Related]
32. Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes.
Henninger N; Goddeau RP; Karmarkar A; Helenius J; McManus DD
Stroke; 2016 Jun; 47(6):1486-92. PubMed ID: 27217503
[TBL] [Abstract][Full Text] [Related]
33. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
[TBL] [Abstract][Full Text] [Related]
34. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
Daniels LB; Clopton P; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Anand IS; Wu AH; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Filippatos GS; Di Somma S; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
Eur J Heart Fail; 2012 Jan; 14(1):22-31. PubMed ID: 22140234
[TBL] [Abstract][Full Text] [Related]
35. Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time.
Arnold M; Nakas C; Luft A; Christ-Crain M; Leichtle A; Katan M
Stroke; 2020 Jun; 51(6):1873-1875. PubMed ID: 32216532
[TBL] [Abstract][Full Text] [Related]
36. Outcome prediction and temperature dependency of MR-proANP and Copeptin in comatose resuscitated patients.
Broessner G; Hasslacher J; Beer R; Lackner P; Lehner GF; Harler U; Schiefecker A; Helbok R; Pfausler B; Hammerer-Lercher A; Joannidis M
Resuscitation; 2015 Apr; 89():75-80. PubMed ID: 25619444
[TBL] [Abstract][Full Text] [Related]
37. Serum proatrial natriuretic peptide concentrations during oral glucose-induced acute hyperinsulinemia in lean and obese men.
Asferg CL; Nielsen SJ; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
Peptides; 2019 Jan; 111():98-102. PubMed ID: 29524563
[TBL] [Abstract][Full Text] [Related]
38. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
[TBL] [Abstract][Full Text] [Related]
39. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.
Miller WL; Hartman KA; Grill DE; Struck J; Bergmann A; Jaffe AS
Heart; 2012 Mar; 98(5):389-94. PubMed ID: 22194151
[TBL] [Abstract][Full Text] [Related]
40. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
von Haehling S; Papassotiriou J; Hartmann O; Doehner W; Stellos K; Geisler T; Wurster T; Schuster A; Botnar RM; Gawaz M; Bigalke B
Clin Sci (Lond); 2012 Nov; 123(10):601-10. PubMed ID: 22690794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]